SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001743929-23-000002
Filing Date
2023-02-08
Accepted
2023-02-08 19:37:48
Documents
1
Period of Report
2022-12-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1523
  Complete submission text file 0001743929-23-000002.txt   3244
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Issuer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 400 SOUTH AUSTRALIAN AVENUE SUITE 800 WEST PALM BEACH FL 33401
Business Address
McLennan Marlene (Reporting) CIK: 0001743929 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34810 | Film No.: 23600645